Compound Profile: Letrozol 2.
Letrozol 2.5mg Sterling Knight is a third-generation non-steroidal aromatase inhibitor specifically formulated for sophisticated laboratory investigations into estrogen biosynthesis pathways. This research compound demonstrates exceptional selectivity for CYP19A1 enzyme inhibition, making it invaluable for researchers examining hormonal modulation mechanisms in controlled laboratory environments. The Sterling Knight formulation offers consistent potency for reproducible experimental outcomes across multiple research protocols.
Research facilities studying endocrine disruption models frequently utilise this compound alongside other investigational materials available through Stroid UK Shop to examine complex hormonal interactions. The 2.5mg dosage provides precise analytical control for dose-response relationship studies in cellular and molecular biology applications.
Research Applications and Investigations
Laboratory studies investigating letrozole focus primarily on its mechanism as a competitive inhibitor of aromatase enzyme activity. Research applications include examining estrogen-dependent cellular proliferation models, investigating hormonal feedback mechanisms, and evaluating endocrine system responses in various experimental paradigms. Scientists analyse this compound’s effects on estradiol synthesis pathways and its potential interactions with other hormonal modulators.
Comparative studies often examine letrozole alongside compounds from estrogen blocker research categories to understand differential mechanisms of action. Research teams also investigate potential synergistic effects when combined with selective androgen receptor modulators and peptide compounds in multi-factorial experimental designs.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Letrozole |
| Concentration | 2.5mg per tablet |
| Molecular Formula | C17H11N5 |
| Molecular Weight | 285.3 g/mol |
| CAS Number | 112809-51-5 |
| Storage Conditions | Cool, dry environment below 25°C |
| Research Grade | Laboratory standard |
| Manufacturer | Sterling Knight |
Research Compliance and Safety
This product is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory safety protocols and comply with all relevant institutional guidelines when handling this compound. Proper documentation and research oversight are essential for all experimental applications involving this material.
